What does the evidence say about Evening Primrose Oil Skin Barrier Randomized Trial?

The current Migaku evidence database contains 1 reusable source document for Evening Primrose Oil Skin Barrier Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - In rheumatoid arthritis, mixed results were observed, with some studies reporting significant improvements in symptoms while others found no significant impact. [Sharifi M (2024); evidence level 1] - However, it did not demonstrate effectiveness in chronic hand dermatitis, tardive dyskinesia, psoriatic arthritis, cystic fibrosis, hepatitis B, premenstrual syndrome, contact lens-associated dry eyes, acne vulgaris, breast cyst, pre-eclampsia, psoriasis, or primary Sjogren's syndrome. [Sharifi M (2024); evidence level 1] - Conclusion Some evidence regarding the potential benefits of EPO in inflammatory disorders were reported however caution is due to the limitations of the current survey. [Sharifi M (2024); evidence level 1] - Background Evening primrose oil (EPO), extracted from the seeds of Oenothera biennis, has gained attention for its therapeutic effects in various inflammatory conditions. [Sharifi M (2024); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.